Zheng et al. studied the role of the NRF2 activators sulforaphane (more below) and cinnamic aldehyde in a STZ-induced diabetic nephropathy model in Nrf2 wild-type and knockout mice. This evidence concerns the gene NFE2L2 and diabetic kidney disease.